See All Slides - tctmd.com

Slides

Presentation THT 2025

Setting Pace in HFpEF: The Rationale for Personalized Heart Rates

Presenter: Harriette Van Spall

February 11, 2025

Presentation THT 2025

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Presenter: Philipp Lurz

February 11, 2025

Presentation THT 2025

Preserving Access: Limiting the Use of Advanced Therapies

Presenter: Gerin Stevens

February 11, 2025

Presentation THT 2025

Increasing Access: Using Team-Based Care to Get STRONG

Presenter: Laura Cohen

February 11, 2025

Presentation THT 2025

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Presenter: Kavita Sharma

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study

Presenter: Kevin Croce

February 11, 2025

Presentation THT 2025

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Presenter: Gad Cotter

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Presenter: Isabela Landsteiner

February 11, 2025

Advertisement

Slides

Setting Pace in HFpEF: The Rationale for Personalized Heart Rates

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Preserving Access: Limiting the Use of Advanced Therapies

Increasing Access: Using Team-Based Care to Get STRONG

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content